GLMD
Price
$1.42
Change
-$0.02 (-1.39%)
Updated
Apr 1 closing price
Capitalization
2.35M
35 days until earnings call
SRPT
Price
$61.86
Change
-$1.96 (-3.07%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
6.19B
28 days until earnings call
Ad is loading...

GLMD vs SRPT

Header iconGLMD vs SRPT Comparison
Open Charts GLMD vs SRPTBanner chart's image
Galmed Pharmaceuticals
Price$1.42
Change-$0.02 (-1.39%)
Volume$52.73K
Capitalization2.35M
Sarepta Therapeutics
Price$61.86
Change-$1.96 (-3.07%)
Volume$101.22K
Capitalization6.19B
GLMD vs SRPT Comparison Chart
Loading...
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLMD vs. SRPT commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLMD is a StrongBuy and SRPT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (GLMD: $1.44 vs. SRPT: $63.82)
Brand notoriety: GLMD: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLMD: 5% vs. SRPT: 300%
Market capitalization -- GLMD: $2.35M vs. SRPT: $6.19B
GLMD [@Biotechnology] is valued at $2.35M. SRPT’s [@Biotechnology] market capitalization is $6.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLMD’s FA Score shows that 0 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • GLMD’s FA Score: 0 green, 5 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, both GLMD and SRPT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLMD’s TA Score shows that 3 TA indicator(s) are bullish while SRPT’s TA Score has 4 bullish TA indicator(s).

  • GLMD’s TA Score: 3 bullish, 5 bearish.
  • SRPT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SRPT is a better buy in the short-term than GLMD.

Price Growth

GLMD (@Biotechnology) experienced а -29.06% price change this week, while SRPT (@Biotechnology) price change was -16.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.07%. For the same industry, the average monthly price growth was -13.26%, and the average quarterly price growth was -12.25%.

Reported Earning Dates

GLMD is expected to report earnings on May 07, 2025.

SRPT is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-9.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRPT($6.19B) has a higher market cap than GLMD($2.35M). SRPT has higher P/E ratio than GLMD: SRPT (26.46) vs GLMD (0.02). SRPT YTD gains are higher at: -47.512 vs. GLMD (-54.859). SRPT has higher annual earnings (EBITDA): 317M vs. GLMD (-6.7M). SRPT has more cash in the bank: 1.36B vs. GLMD (17.1M). GLMD has less debt than SRPT: GLMD (41K) vs SRPT (1.34B). SRPT has higher revenues than GLMD: SRPT (1.9B) vs GLMD (0).
GLMDSRPTGLMD / SRPT
Capitalization2.35M6.19B0%
EBITDA-6.7M317M-2%
Gain YTD-54.859-47.512115%
P/E Ratio0.0226.460%
Revenue01.9B-
Total Cash17.1M1.36B1%
Total Debt41K1.34B0%
FUNDAMENTALS RATINGS
GLMD vs SRPT: Fundamental Ratings
GLMD
SRPT
OUTLOOK RATING
1..100
9662
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9746
PRICE GROWTH RATING
1..100
9694
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLMD's Valuation (41) in the Pharmaceuticals Other industry is in the same range as SRPT (71) in the Biotechnology industry. This means that GLMD’s stock grew similarly to SRPT’s over the last 12 months.

GLMD's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as SRPT (100) in the Biotechnology industry. This means that GLMD’s stock grew similarly to SRPT’s over the last 12 months.

SRPT's SMR Rating (46) in the Biotechnology industry is somewhat better than the same rating for GLMD (97) in the Pharmaceuticals Other industry. This means that SRPT’s stock grew somewhat faster than GLMD’s over the last 12 months.

SRPT's Price Growth Rating (94) in the Biotechnology industry is in the same range as GLMD (96) in the Pharmaceuticals Other industry. This means that SRPT’s stock grew similarly to GLMD’s over the last 12 months.

GLMD's P/E Growth Rating (94) in the Pharmaceuticals Other industry is in the same range as SRPT (100) in the Biotechnology industry. This means that GLMD’s stock grew similarly to SRPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLMDSRPT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 15 days ago
85%
Bullish Trend 9 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
66%
View a ticker or compare two or three
Ad is loading...
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BFST24.35-0.13
-0.53%
Business First Bancshares
FRD14.89-0.19
-1.26%
Friedman Industries
TGS26.46-0.81
-2.97%
Transportadora de Gas del Sur SA
RGEN127.24-6.17
-4.62%
Repligen Corp
NXU2.67-0.37
-12.17%
Nxu Inc